CLINICAL TRIALS PROFILE FOR PROBENECID; SULOPENEM ETZADROXIL
✉ Email this page to a colleague
All Clinical Trials for PROBENECID; SULOPENEM ETZADROXIL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04700787 ↗ | Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents | Not yet recruiting | Iterum Therapeutics, International Limited | Phase 1 | 2021-01-21 | The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous sulopenem and oral sulopenem etzadroxil/probenecid in adolescent patients. |
NCT03357614 ↗ | Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults | Completed | Iterum Therapeutics, International Limited | Phase 3 | 2018-09-18 | This is a prospective, phase 3, randomized, multicenter, double-blind, double-dummy study to compare the efficacy and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for the treatment of complicated urinary tract infections (cUTI) in adults. |
NCT03357614 ↗ | Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults | Completed | Iterum Therapeutics, US Limited | Phase 3 | 2018-09-18 | This is a prospective, phase 3, randomized, multicenter, double-blind, double-dummy study to compare the efficacy and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for the treatment of complicated urinary tract infections (cUTI) in adults. |
NCT03358576 ↗ | Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI) | Completed | Iterum Therapeutics, International Limited | Phase 3 | 2018-09-18 | This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin-metronidazole for treatment of complicated intra-abdominal infections in adults. |
NCT03358576 ↗ | Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI) | Completed | Iterum Therapeutics, US Limited | Phase 3 | 2018-09-18 | This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin-metronidazole for treatment of complicated intra-abdominal infections in adults. |
NCT03354598 ↗ | Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women | Completed | Iterum Therapeutics, International Limited | Phase 3 | 2018-08-01 | This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women |
NCT03354598 ↗ | Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women | Completed | Iterum Therapeutics, US Limited | Phase 3 | 2018-08-01 | This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PROBENECID; SULOPENEM ETZADROXIL
Condition Name
Clinical Trial Locations for PROBENECID; SULOPENEM ETZADROXIL
Trials by Country
Clinical Trial Progress for PROBENECID; SULOPENEM ETZADROXIL
Clinical Trial Phase
Clinical Trial Sponsors for PROBENECID; SULOPENEM ETZADROXIL
Sponsor Name